GreenShield and Women’s Health Collective Canada (WHCC) have partnered to fund Canada’s first national menopause study, researching how the transition affects women in Canadian workplaces, healthcare systems, and communities.
Uncover why to include Latin America in Canadian Femtech growth plans. See how LATAM’s ecosystem offers strong clinical testing and market potential.
Cross-Border Impact Ventures (CBIV) announced the first close of its second fund, the Women’s and Children’s Health Technology Fund II, securing US$58 million toward a target fund size of US$125
Nila is a collection of hundreds of evidence-based pieces of research on hormone-related conditions. These extend beyond perimenopause and menopause, including endometriosis, autoimmune disease and cancer.
Vitalité Health Network becomes the first Canadian site to join Breathe BioMedical’s multi-center study to advance development of its technology for early detection of breast cancer in women
Elle MD Technologies has raised $1.1 million CAD to do clinical testing with its vaginal ring, called the Livv.
WEL Manitoba recently voted to fund Marlow, a health startup that aims to revolutionize period care with the first-ever lubricated tampon designed for smoother and more comfortable insertion.
Nila’s Android app has entered closed testing on Google Play, three weeks after the iOS app launched to a 5-star early rating.
The Government of Ontario announced its investment in wHealth Ignite program to support women’s health innovation
Women’s health innovation is growing rapidly. By bringing together innovators, clinicians, researchers, and healthcare leaders, the Femtech Canada–SOGC partnership aims to ensure that promising solutions have the support, evidence, and
Our website uses cookies to ensure you get the best experience. Learn more about the policy.